| Peripheral arterial disease in people with diabetes American Diabetes Association Diabetes care 26 (12), 3333, 2003 | 1438 | 2003 |
| Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. AE Caballero, S Arora, R Saouaf, SC Lim, P Smakowski, JY Park, GL King, ... Diabetes 48 (9), 1856-1862, 1999 | 937 | 1999 |
| Vascular and microvascular disease of the foot in diabetes: implications for foot care FW LoGerfo, JD Coffman New England Journal of Medicine 311 (25), 1615-1619, 1984 | 724 | 1984 |
| Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients DR Snydman, BG Werner, B Heinze-Lacey, VP Berardi, NL Tilney, ... New England Journal of Medicine 317 (17), 1049-1054, 1987 | 671 | 1987 |
| Major lower extremity amputation: outcome of a modern series B Aulivola, CN Hile, AD Hamdan, MG Sheahan, JR Veraldi, JJ Skillman, ... Archives of surgery 139 (4), 395-399, 2004 | 643 | 2004 |
| Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. A Veves, CM Akbari, J Primavera, VM Donaghue, D Zacharoulis, ... Diabetes 47 (3), 457-463, 1998 | 504 | 1998 |
| A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases FB Pomposelli, N Kansal, AD Hamdan, A Belfield, M Sheahan, ... Journal of vascular surgery 37 (2), 307-315, 2003 | 497 | 2003 |
| Dorsalis pedis arterial bypass: durable limb salvage for foot ischemia in patients with diabetes mellitus FB Pomposelli Jr, EJ Marcaccio, GW Gibbons, DR Campbell, ... Journal of vascular surgery 21 (3), 375-384, 1995 | 338 | 1995 |
| Inflammation and neuropeptides: the connection in diabetic wound healing L Pradhan, C Nabzdyk, ND Andersen, FW LoGerfo, A Veves Expert reviews in molecular medicine 11, e2, 2009 | 286 | 2009 |
| Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery CD Owens, PM Ridker, M Belkin, AD Hamdan, F Pomposelli, F Logerfo, ... Journal of Vascular Surgery 45 (1), 2-9, 2007 | 273 | 2007 |
| Trends in the care of the diabetic foot: expanded role of arterial reconstruction FW LoGerfo, GW Gibbons, FB Pomposelli, DR Campbell, A Miller, ... Archives of Surgery 127 (5), 617-621, 1992 | 251 | 1992 |
| Downstream anastomotic hyperplasia. A mechanism of failure in Dacron arterial grafts. FW LoGerfo, WC Quist, MD Nowak, HM Crawshaw, CC Haudenschild Annals of surgery 197 (4), 479, 1983 | 247 | 1983 |
| A comparative study of alternative conduits for lower extremity revascularization: all-autogenous conduit versus prosthetic grafts PL Faries, FW LoGerfo, S Arora, S Hook, MC Pulling, CM Akbari, ... Journal of vascular surgery 32 (6), 1080-1090, 2000 | 233 | 2000 |
| Diabetes and peripheral vascular disease CM Akbari, FW LoGerfo Journal of vascular surgery 30 (2), 373-384, 1999 | 211 | 1999 |
| Endothelium-dependent vasodilatation is impaired in both microcirculation and macrocirculation during acute hyperglycemia CM Akbari, R Saouaf, DF Barnhill, PA Newman, FW LoGerfo, A Veves Journal of vascular surgery 28 (4), 687-694, 1998 | 210 | 1998 |
| Substance P promotes wound healing in diabetes by modulating inflammation and macrophage phenotype EC Leal, E Carvalho, A Tellechea, A Kafanas, F Tecilazich, C Kearney, ... The American journal of pathology 185 (6), 1638-1648, 2015 | 206 | 2015 |
| Poly (ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity C Szabó, A Zanchi, K Komjáti, P Pacher, AS Krolewski, WC Quist, ... Circulation 106 (21), 2680-2686, 2002 | 205 | 2002 |
| Differences in foot and forearm skin microcirculation in diabetic patients with and without neuropathy S Arora, P Smakowski, RG Frykberg, LR Simeone, R Freeman, ... Diabetes care 21 (8), 1339-1344, 1998 | 187 | 1998 |
| Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals … SC Lim, AE Caballero, P Smakowski, FW LoGerfo, ES Horton, A Veves Diabetes care 22 (11), 1865-1870, 1999 | 183 | 1999 |
| The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial AE Caballero, R Saouaf, SC Lim, O Hamdy, K Abou-Elenin, C O'Connor, ... Metabolism 52 (2), 173-180, 2003 | 182 | 2003 |
